Key facts
- Notable investors include Enterprise Ireland, Propelor BIC.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Genotrial
- ·The full record, as it builds
Funding rounds
No funding rounds for Genotrial are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genotrial
Developer of an AI-powered patient matching platform designed to revolutionize clinical trial recruitment by instantly connecting patients to medical research through genomic and health record analysis. The company's specialized trial platform analyzes unstructured health records and genomic data in a short time, enabling clients to drastically accelerate the trial recruitment process and improve patient outcomes through precision medicine.
- Sector
- Healthcare
- HQ
- Kilkenny, Ireland
- Founded
- 2024
- Employees
- 4
- Website
- genotrial.com/
- Ownership
- Privately Held (backing)
Genotrial doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genotrial shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genotrial in its N-PORT filings yet. We sweep new filings monthly.